BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:[ Johnson & Johnson Innovation:  Improving Detection of Neurotoxic
 ity in Immunotherapies ]
DTSTART;VALUE=DATE:20220318
DTSTAMP:20260510T164800Z
UID:625eef3f7754a7d023eb2f9848f652b4772bdebd36668228075bd821
CATEGORIES:Call for proposal
DESCRIPTION:Aim:  Visionaries are invited to submit methods and technolog
 ies aiming to optimize patient care for immunotherapies within the hematol
 ogic malignancy space by enabling early detection of neurotoxic events. Of
  particular interest are technologies aiming to identify clinical manifest
 ations to predict acute toxicities\, including movement and neurocognitive
  disorders.\n\nAmount: Increments up to $200\,000\, $125\,000 or $75\,000\
 n\nAdditional Perks:  Access to the global Johnson & Johnson innovation 
 – JLABS network and mentorship from experts at the Johnson & Johnson Fam
 ily of Companies.\n\nDeadline:  18 March 2022\n\nEligibility / Criteria:
    Potential solutions will be evaluated by an independent panel of revi
 ewers and judges on their ability to meet the following criteria:\n\n	Accu
 racy in detecting and characterizing clinical manifestations\, with a spec
 ific interest in variations in handwriting including micrographia\, dysgra
 phia\, and agraphia\n	Patient accessibility\n	Seamlessly integrates into h
 ealthcare settings and existing patient care model\n	Feasibility and plans
  for deployment\n	Potential impact\n\nHow to apply: \nClick on the Apply n
 ow button just below the introductory photo on the following link: Improvi
 ng Detection of Neurotoxicity in Immunotherapies\n\nFor further informatio
 n:\nPlease contact the Research Office in the event you have questions or 
 wish to apply to this opportunity.
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR